Journal article icon

Journal article

Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.

Publication status:
Published

Actions


Authors



Journal:
JOURNAL OF CLINICAL ONCOLOGY More from this journal
Volume:
28
Issue:
15
Publication date:
2010-05-20
ISSN:
0732-183X


Pubs id:
pubs:457370
UUID:
uuid:878464f8-20b8-48d9-bfd0-7340ce914549
Local pid:
pubs:457370
Source identifiers:
457370
Deposit date:
2014-05-14

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP